Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06261736 · ClinicalTrials.gov registry record · NA
The Effectiveness of Prophylactic Antibiotics for Urethral Bulking
A NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection, sponsored by Atlantic Health System.
- Recruiting
- Registry status
- NA
- Development phase
- 70
- Enrollment target
- 1
- Study location
NCT06261736: Recruiting NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection, sponsored by Atlantic Health System.
NCT06261736 is a NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection that is actively recruiting participants, run by Atlantic Health System. The registered enrollment target is 70 participants, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (57% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06261736, a NA study of Stress Urinary Incontinence and Postoperative Urinary Tract Infection, is actively recruiting participants, sponsored by Atlantic Health System.
- RECRUITING
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.
Primary Outcome
The rate of UTI based on symptoms and a positive urine culture
Conditions Studied
Interventions
- OTHER Prophylactic antibiotics
- OTHER No antibiotics
Study Locations (1)
New Jersey
- Atlantic Health - Morristown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2023-10-24 |
| Est. Completion | 2026-01 |
| Phase | NA |
What NCT06261736 shows while recruiting
NCT06261736 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 161-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (57% lower).
The record links to 3 conditions, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which Prophylactic antibiotics is the first listed.
NCT06261736 reports a single indexed study location in New Jersey.
Frequently Asked Questions
What is clinical trial NCT06261736 about?
NCT06261736 is a clinical study titled "The Effectiveness of Prophylactic Antibiotics for Urethral Bulking". The goal of this clinical trial is to evaluate if prophylactic antibiotics in urethral bulking are effective in reducing postprocedural urinary tract infections.
What is the current status of trial NCT06261736?
This trial is currently recruiting. It is a NA study. The enrollment target is 70 participants. The study started on 2023-10-24. Estimated completion is 2026-01.
What conditions does trial NCT06261736 study?
This clinical trial studies the following conditions: Stress Urinary Incontinence, Postoperative Urinary Tract Infection, Urethral Bulking.
What interventions are being tested in trial NCT06261736?
The interventions under investigation include: Prophylactic antibiotics (OTHER), No antibiotics (OTHER).
Who is sponsoring clinical trial NCT06261736?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06261736 being conducted?
This trial has 1 study location across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Urinary Incontinence
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06261736's enrollment target sits among peer trials
70 24th of 35 higher than 11 of 35 other Stress Urinary Incontinence trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Urinary Incontinence trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
ProACT Post-Approval Study
RECRUITING · NA
-
Trial of Transurethral Bulking Agent Injection Versus Single-Incision Sling for Stress Urinary Incontinence
RECRUITING · NA
-
Comparison of Virtual Pelvic Floor Physical Therapy With a Pelvic Floor Trainer in the Treatment of Stress Urinary Incontinence.
RECRUITING · NA
-
Impact of Unrestrictive Exercise Following Mid-Urethral Sling Surgery
RECRUITING · NA
-
Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy
RECRUITING · NA
-
BELIEVE Trial: Bulking vErsus sLing for Treating Stress Urinary IncontinEnce at the Time of Vaginal prolapsE Repair (BELIEVE)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI